Indoximod opposes the immunosuppressive effects mediated by IDO and TDO via modulation of AhR function and activation of mTORC1

Indoximod has shaped our understanding of the biology of IDO1 in the control of immune responses, though its mechanism of action has been poorly understood. Previous studies demonstrated that indoximod creates a tryptophan (Trp) sufficiency signal that reactivates mTOR in the context of low Trp conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Brincks, Erik L., Adams, James, Wang, Lifu, Turner, Benjamin, Marcinowicz, Agnieszka, Ke, Jiyuan, Essmann, Michael, Mautino, Lucía M., Allen, Clarissa Van, Kumar, Sanjeev, Vahanian, Nicholas, Link, Charles, Mautino, Mario R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321702/
https://www.ncbi.nlm.nih.gov/pubmed/32637034
http://dx.doi.org/10.18632/oncotarget.27646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321702/
https://www.ncbi.nlm.nih.gov/pubmed/32637034
http://dx.doi.org/10.18632/oncotarget.27646

Ejemplares similares